Freshpet (FRPT)
(Delayed Data from NSDQ)
$129.25 USD
+1.20 (0.94%)
Updated Jun 27, 2024 04:00 PM ET
After-Market: $129.50 +0.25 (0.19%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$129.25 USD
+1.20 (0.94%)
Updated Jun 27, 2024 04:00 PM ET
After-Market: $129.50 +0.25 (0.19%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth C Momentum D VGM
Zacks News
Monster Beverage's (MNST) Strategies Seem Prudent: Apt to Hold
by Zacks Equity Research
Monster Beverage (MNST) sees strength in its energy drinks category. In addition, the company's expansion strategy bodes well.
McCormick (MKC) Q2 Earnings Top Estimates, Volumes Down
by Zacks Equity Research
McCormick's (MKC) second-quarter earnings reflect gains from strong brands and a focus on high-growth areas. However, lower volumes acted as a deterrent.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
by Zacks Equity Research
Sector ETF report for FXG
Colgate's (CL) Strategic Efforts Seem Prudent: Apt to Hold?
by Zacks Equity Research
Colgate (CL) benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Can Molson Coors' (TAP) Revitalization Plan Aid Amid Cost Woes?
by Zacks Equity Research
Molson Coors' (TAP) Revitalization plan, premiumization efforts and cost-saving plan place it well for long-term growth amid rising costs due to inflationary woes.
Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXG
Strong Brands Aid Helen of Troy (HELE), Macro Headwinds Hurt
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in its Leadership Brands. Persistent inflation and rising interest rates are prompting cautious spending behavior.
Energizer's (ENR) Debt Reduction Aids Amid Soft Battery Unit
by Zacks Equity Research
Energizer (ENR) excels in financial strength and strategic growth, reducing debt and boosting profitability, positioning itself as a stable investment with promising prospects.
Altria's (MO) Smoke-Free Growth Underway With Latest FDA Nod
by Zacks Equity Research
Altria's (MO) NJOY obtains authorization from the U.S. Food and Drug Administration for menthol e-vapor products.
Beat the Market Like Zacks: Freshpet, AudioEye, Walmart in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Church & Dwight (CHD) Thrives on Brand Strength Amid Cost Woes
by Zacks Equity Research
Church & Dwight (CHD) is committed to bolstering its portfolio via consistent innovation, new product launches and strategic acquisitions.
Tyson Foods (TSN) Advances Growth Pillars & Boosts Efficiency
by Zacks Equity Research
Tyson Foods (TSN) is on track with its growth strategy based on three main pillars, including driving growth in the core protein platform. It has taken bold actions to enhance operational efficiency.
Here's Why Clorox's (CLX) Strategic Efforts Appear Good
by Zacks Equity Research
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Kimberly-Clark (KMB) Up More Than 15% in 6 Months: Here's Why
by Zacks Equity Research
Focus on innovation, consumer-centric approach and strategic investments in product development is driving Kimberly-Clark's (KMB) performance.
Why Freshpet (FRPT) Outpaced the Stock Market Today
by Zacks Equity Research
Freshpet (FRPT) reachead $131.21 at the closing of the latest trading day, reflecting a +1.16% change compared to its last close.
RH Q1 Loss Wider Than Expected, Revenues Decrease Y/Y
by Zacks Equity Research
RH's first-quarter fiscal 2024 results reflect the impact of higher interest rates in April.
Diageo (DEO), Tolaram Alliance to Aid Growth in Guinness Nigeria
by Zacks Equity Research
Diageo (DEO) benefits from its focus on improving productivity coupled with its diversified footprint, a solid portfolio of brands, innovation and pricing.
Freshpet (FRPT) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Freshpet (FRPT) closed at $128.17 in the latest trading session, marking a -1.35% move from the prior day.
Molson Coors' (TAP) Premium Brands Place It Well: Apt to Hold?
by Zacks Equity Research
Molson Coors (TAP) looks steady on efforts to boost market share through innovation and premiumization amid rising inflationary cost pressures.
Energizer's (ENR) Auto Care Unit Aids Amid Battery Unit Hurdles
by Zacks Equity Research
Energizer (ENR) is implementing initiatives for sustainable growth and profitability, focusing on consumer engagement and pricing strategies to enhance brand loyalty and increase market share.
RH Gears Up to Report Q1 Earnings: Here's What to Expect
by Zacks Equity Research
RH's fiscal first-quarter results are likely to reflect high mortgage rates, a soft luxury housing market and clearance pressure.
Monster Beverage's (MNST) Expansion Strategy Bodes Well
by Zacks Equity Research
Monster Beverage (MNST) sees strength in its energy drinks category. In addition, the company's expansion strategy bodes well.
Colgate (CL) Benefits From Innovation and Pricing Strategies
by Zacks Equity Research
Colgate (CL) seems well-poised for growth due to its innovation strategies, pricing actions, digital investments and revenue growth management initiatives.
Estee Lauder (EL) Concludes Buyout of DECIEM, Boosts Portfolio
by Zacks Equity Research
Estee Lauder's (EL) acquisition of DECIEM, the innovative "Abnormal Beauty Company," enhances its skincare lineup, fostering global expansion.
The Zacks Analyst Blog Highlights BRF, Freshpet, Vital Farms, Utz Brands and Ingredion
by Zacks Equity Research
BRF, Freshpet, Vital Farms, Utz Brands and Ingredion are part of the Zacks top Analyst Blog.